Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Brawley › NPI 1760995625
Hospital

Pioneers Memorial Healthcare District

Pioneers Memorial Healthcare District was paid $10.84M by Medicaid between Mar 2018 and Sep 2024, across 51 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 87% of everything it billed.

33Billing provider infoPIONEERS MEMORIAL HEALTHCARE DISTRICT
BRAWLEY, CA 92227
33aNPI1760995625assigned 11/14/2017
28Total paid$10.84M
24GClaims159,706
24DCodes billed51
24AFirst – last monthMar 2018 – Sep 2024
Compared with peers

Next to other Rural Acute Care Hospital providers in California

Rank by total paid#2 of 6
Median peer was paid$397K
This provider vs. median27×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20187,768$624K
201925,982$2.23M
202022,755$1.60M
202132,906$1.80M
202229,299$1.62M
202330,712$2.13M
2024incomplete10,284$837K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 87% 38,129 29,721 $9.41M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2.3% 25,056 22,062 $252K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2.2% 16,043 13,361 $241K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.2% 3,116 2,975 $129K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1.1% 5,132 5,121 $114K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,452 1,412 $86K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 4,203 4,159 $84K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 2,327 2,316 $67K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,028 1,002 $54K
92552 <1% 5,491 5,461 $54K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 1,137 1,131 $49K
J3490 Unclassified drugs <1% 6,128 6,096 $43K
39 more codes
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 1,084 $39K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 4,709 $34K
87486 <1% 2,543 $33K
87581 <1% 2,542 $32K
G0071 Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only <1% 712 $17K
99203 Doctor's office visit, new patient (routine) <1% 124 $10K
99383 <1% 134 $10K
86580 <1% 5,331 $10K
99173 <1% 5,340 $9K
99384 <1% 100 $9K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,553 $8K
99000 <1% 3,866 $8K
99382 <1% 98 $7K
85018 <1% 5,749 $6K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,384 $6K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 1,259 $5K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 7,356 $3K
90461 <1% 4,390 $3K
99214 Doctor's office visit, returning patient (more involved) <1% 36 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 153 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 466 $1K
0250 <1% 126 $1K
83655 <1% 146 $945.89
0259 <1% 75 $809.54
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 12 $615.72
99201 <1% 15 $502.35
81003 <1% 275 $379.03
87086 Culture, bacterial; quantitative colony count, urine <1% 95 $282.20
81001 <1% 176 $252.44
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 13 $225.00
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 13 $204.75
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 66 $6.29
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 0% 322 $0.00
90677 0% 23 $0.00
99381 0% 42 $0.00
90697 0% 20 $0.00
99441 0% 73 $0.00
Z7610 0% 26 $0.00
90680 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEWIS, LAWRENCE (CEO)
Parent organizationPIONEERS MEMORIAL HEALTHCARE DISTRICT